Microbial solutions for a sustainable future
Driven by advances in genomics technology, rising oil prices, and a growing interest in ecological sustainability, the world is increasingly turning to industrial biotechnology to create renewable sources of products for use in pharmaceuticals, foods, and specialty and industrial chemicals.
We at Microbia PE have emerged as leaders in this field, having developed a proven technology platform that combines high-throughput biology with a proprietary approach to engineering microbial metabolic pathways. This platform enables us to produce high-quality, competitively-priced metabolites from renewable resources.
A majority-owned subsidiary of Ironwood Pharmaceuticals, Microbia PE is building a sustainable specialty chemical business based on our validated and versatile industrial strain development platform.